Deformity Market Research Report – Global Forecast till 2023

Deformity Market Research Report – Global Forecast till 2023

ID: MRFR/HC/3589-HCRR | | Region: Global | 110 pages | Half-Cooked Research Reports

Deformity Market Research Report: By Types (Congenital, Acquired), Therapy (Diagnosis (Magnetic Resonance Imaging, Computed Tomography Scan, Bone Scan), Treatment), By End Users (Hospital & Clinics, Orthopedic Care Centers) - Global Forecast till 2023 


Market Scenario


Deformity is the malformation of any component of the body leading to an impairment or functional loss of the organ. The condition results in the bony alteration in the topography of soft tissues. The exact cause for the disease is still unknown. However, genetic mutation, damage during the foetal stage, complications at birth, hormonal disorder, arthritis along with other causes are expected to cause this disease. Increasing prevalence of deformity is the major driving factor for the growth of the market. According to the Physicians Committee (2015), approximately 3% of all children born in the U.S. suffer major malformations at birth. Additionally, over 150,000 babies are born each year with birth defects. Though, in early stages the disease is acute, however if the proper treatment is not taken it may led to serious conditions. A number of diagnostic procedures are available in the market for the diagnosis of deformities. A number of companies are involved in the manufacturing of innovative and effective treatment options for the patients. Besides, the increasing government support and rising healthcare expenditure are also supporting the growth of the market. Furthermore, rapid development in the imaging technology and continuous improvement in the medical services have fuelled the market growth. As there is no precise treatment available in the market and the cost associated with the surgeries is very high which is not affordable for people in the developing regions. Thus, lack of the precise treatment and high cost of surgeries may slow the growth of the market.


The global deformity market is expected to grow at a CAGR of 7.1% during forecast period 2017-2023. 


Intended Audience



  • Biotechnological institutes

  • Pharmaceutical companies

  • Government and Private Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories


Figure 1:- Global Deformity market share, by region (%)

Deformity Market


Sources: WHO, annual reports, press release, white paper, and company presentation


 


Segmentation


The global deformity market is segmented on the basis of types, therapy and end users.


On the basis of types, the market is segmented into congenital, and acquired. Congenital deformity is further segmented into Sprangel’s shoulder, elbow joint congenital dislocation, and others.


On the basis of therapy, the market is the market is segmented into diagnosis and treatment. Diagnosis is further segmented into MRI, CT scan, bone scan and others. Treatment is further categorized into medical therapy, surgical therapy, postoperative care, long-term monitoring and others.


On the basis of end users, the market is segmented into hospital & clinics, orthopedic care centers and others. 


Regional Analysis


The Americas dominates the global deformity market owing to large patient population. According to the Physicians Committee (2015), approximately 3% of all children born in the U.S. have a major malformation at birth. Increasing number of people suffering from deformity and other bones disease have driven the growth of the Americas deformity market. Additionally, increasing government support for research & development, availability of funds for research, and high per capita income will fuel the growth of the market. Increasing awareness among people regarding the disease and well-developed technology will create opportunities for the development of the market.


Europe accounts for the second leading deformity market, which is followed by Asia Pacific. Increasing patient population, availability of funds for research, and government support for research & development projected to drive the market in Europe. Germany, France and U.K is expected to lead the European market.


Asia Pacific is the fastest growing region in the global deformity market owing to rapidly increasing population, the developing economies and rising demand for the better treatment options for the diseases. India and China holds the major share of the market.


Whereas, the Middle East & Africa owns the least share of the global deformity market due to the presence of poor economy, especially, in the Africa region. The market of this region is dominated by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure. However, Africa region shows the fastest growth for the market. 


Research Methodology



Global Deformity Market


Sources: WHO, annual reports, press release, white paper, and company presentation


 


Key players in global deformity market


The major key players in the global deformity market: SpineCraft, LCC (U.S.), DePuy Synthes (U.S.), NuVasive (U.S.), OrthoPediatrics Corp. (U.S.), 3M (U.S.), Bristol-Myers Squibb and Company (U.S.), B. Braun (Germany), Stryker Corporation (U.S.), Pfizer Inc. (U.S.), Lineage Medical, Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), Argon Medical Devices, Inc (the Netherlands), and Cook Medical (U.S.).

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Deformity Market, by Types

6.1 Introduction

6.2 Congenital

Market Estimates & Forecast, 2017 – 2023

6.2.1 Sprangel’s Shoulder

6.2.2 Elbow Joint Conginetal Dislocation

6.2.3 Others

6.3 Acquired

Market Estimates & Forecast, 2017 – 2023

Chapter 7. Global Deformity Market, by Therapy

7.1 Introduction

7.2 Diagnosis

Market Estimates & Forecast, 2017 – 2023

7.2.1 MRI

7.2.2 CT Scan

7.2.3 Bone Scan

7.2.4 Others

7.3 Treatment

Market Estimates & Forecast, 2017 – 2023

7.3.1 Medical Therapy

7.3.2 Surgical Therapy

7.3.3 Postoperative Care

7.3.4 Long-Term Monitoring

7.3.5 Others

Chapter 8 Global Deformity Market, by End User

8.1 Introduction

8.2 Hospital & Clinics

Market Estimates & Forecast, 2017 – 2023

8.3 Orthopedic Care Centers

Market Estimates & Forecast, 2017 – 2023

8.4 Others

Market Estimates & Forecast, 2017 – 2023

Chapter 9. Global Deformity Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 U.K

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 SpineCraft, LCC

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 NuVasive

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 OrthoPediatrics Corp.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Pfizer Inc.

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 B. Braun

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 DePuy Synthes

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Bristol-Myers Squibb and Company

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical industry

Chapter 13. Appendix



LIST OF TABLES

Table 1 Deformity Industry Synopsis, 2017 – 2023

Table 2 Global Deformity Market Estimates and Forecast, 2017 – 2023, (USD Million)

Table 3 Global Deformity Market by Region, 2017 – 2023, (USD Million)

Table 4 Global Deformity Market by Types, 2017 – 2023, (USD Million)

Table 5 Global Deformity Market by Therapy, 2017 – 2023, (USD Million)

Table 6 Global Deformity Market by End Users, 2017 – 2023, (USD Million)

Table 7 North America Deformity Market by Types, 2017 – 2023, (USD Million)

Table 8 North America Deformity Market by Therapy, 2017 – 2023, (USD Million)

Table 9 North America Deformity Market by End Users, 2017 – 2023, (USD Million)

Table 10 US Market by Types, 2017 – 2023, (USD Million)

Table 11 US Deformity Market by Therapy, 2017 – 2023, (USD Million)

Table 12 US Deformity Market by End Users, 2017 – 2023, (USD Million)

Table 13 Canada Market by Types, 2017 – 2023, (USD Million)

Table 14 Canada Deformity Market by Therapy, 2017 – 2023, (USD Million)

Table 15 Canada Deformity Market by End Users, 2017 – 2023, (USD Million)

Table 16 South America Market by Types, 2017 – 2023, (USD Million)

Table 17 South America Deformity Market by Therapy, 2017 – 2023, (USD Million)

Table 18 South America Deformity Market by End Users, 2017 – 2023, (USD Million)

Table 19 Europe Market by Types, 2017 – 2023, (USD Million)

Table 20 Europe Deformity Market by Therapy, 2017 – 2023, (USD Million)

Table 21 Europe Deformity Market by End Users, 2017 – 2023, (USD Million)

Table 22 Western Europe Market by Types, 2017 – 2023, (USD Million)

Table 23 Western Europe Deformity Market by Therapy, 2017 – 2023, (USD Million)

Table 24 Western Europe Deformity Market by End Users, 2017 – 2023, (USD Million)

Table 25 Eastern Europe Market by Types, 2017 – 2023, (USD Million)

Table 26 Eastern Europe Deformity Market by Therapy, 2017 – 2023, (USD Million)

Table 27 Eastern Europe Deformity Market by End Users, 2017 – 2023, (USD Million)

Table 28 Asia Pacific Market by Types, 2017 – 2023, (USD Million)

Table 29 Asia Pacific Deformity Market by Therapy, 2017 – 2023, (USD Million)

Table 30 Asia Pacific Deformity Market by End Users, 2017 – 2023, (USD Million)

Table 31 Middle East & Africa Market by Types, 2017 – 2023, (USD Million)

Table 32 Middle East & Africa Deformity Market by Therapy, 2017 – 2023, (USD Million)

Table 33 Middle East & Africa Deformity Market by End Users, 2017 – 2023, (USD Million)





LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Deformity Market

Figure 3 Segmentation Market Dynamics for Global Deformity Market

Figure 4 Global Deformity market Share, by Types 2016

Figure 5 Global Deformity market Share, by Therapy 2016

Figure 6 Global Deformity Market Share, by End Users, 2016

Figure 7 Global Deformity Market Share, by Region, 2016

Figure 8 North America Deformity Market Share, by Country, 2016

Figure 9 Europe Deformity Market Share, by Country, 2016

Figure 10 Asia Pacific Deformity Market Share, by Country, 2016

Figure 11 Middle East & Africa Deformity Market Share, by Country, 2016

Figure 12 Global Deformity Market: Company Share Analysis, 2016 (%)

Figure 13 SpineCraft, LCC: Key Financials

Figure 14 SpineCraft, LCC: Segmental Revenue

Figure 15 SpineCraft, LCC: Geographical Revenue

Figure 16 NuVasive: Key Financials

Figure 17 NuVasive: Segmental Revenue

Figure 18 NuVasive: Geographical Revenue

Figure 19 OrthoPediatrics Corp.: Key Financials

Figure 20 OrthoPediatrics Corp.: Segmental Revenue

Figure 21 OrthoPediatrics Corp.: Geographical Revenue

Figure 22 Pfizer Inc.: Key Financials

Figure 23 Pfizer Inc.: Segmental Revenue

Figure 24 Pfizer Inc.: Geographical Revenue

Figure 25 B. Braun: Key Financials

Figure 26 B. Braun: Segmental Revenue

Figure 27 B. Braun: Geographical Revenue

Figure 28 DePuy Synthes: Key Financials

Figure 29 DePuy Synthes: Segmental Revenue

Figure 30 DePuy Synthes: Geographical Revenue

Figure 31 Bristol-Myers Squibb and Company: Key Financials

Figure 32 Bristol-Myers Squibb and Company: Segmental Revenue

Figure 33 Bristol-Myers Squibb and Company: Geographical Revenue